DK3204399T3 - Lange poly (a)-plasmider og fremgangsmåder til indføring af lange poly (a)-sekvenser i plasmidet - Google Patents
Lange poly (a)-plasmider og fremgangsmåder til indføring af lange poly (a)-sekvenser i plasmidet Download PDFInfo
- Publication number
- DK3204399T3 DK3204399T3 DK15848462.6T DK15848462T DK3204399T3 DK 3204399 T3 DK3204399 T3 DK 3204399T3 DK 15848462 T DK15848462 T DK 15848462T DK 3204399 T3 DK3204399 T3 DK 3204399T3
- Authority
- DK
- Denmark
- Prior art keywords
- long poly
- plasmids
- plasmid
- sequences
- methods
- Prior art date
Links
- 108091034057 RNA (poly(A)) Proteins 0.000 title 2
- 239000013612 plasmid Substances 0.000 title 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0066—Manipulation of the nucleic acid to modify its expression pattern, e.g. enhance its duration of expression, achieved by the presence of particular introns in the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0047—Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462062098P | 2014-10-09 | 2014-10-09 | |
| US201562161107P | 2015-05-13 | 2015-05-13 | |
| PCT/US2015/054780 WO2016057850A1 (en) | 2014-10-09 | 2015-10-08 | Long poly (a) plasmids and methods for introduction of long poly (a) sequences into the plasmid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3204399T3 true DK3204399T3 (da) | 2025-02-24 |
Family
ID=55653811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15848462.6T DK3204399T3 (da) | 2014-10-09 | 2015-10-08 | Lange poly (a)-plasmider og fremgangsmåder til indføring af lange poly (a)-sekvenser i plasmidet |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US9943612B2 (da) |
| EP (2) | EP4553081A1 (da) |
| AU (2) | AU2015330775B2 (da) |
| DK (1) | DK3204399T3 (da) |
| ES (1) | ES3015369T3 (da) |
| WO (1) | WO2016057850A1 (da) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| EP4282419A1 (en) | 2012-12-20 | 2023-11-29 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| US9228207B2 (en) | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
| US20170335331A1 (en) | 2014-10-31 | 2017-11-23 | The Trustees Of The University Of Pennsylvania | Altering Gene Expression in CART Cells and Uses Thereof |
| CA2985650A1 (en) * | 2015-05-13 | 2016-11-17 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Enhancing endonuclease based gene editing in primary cells |
| IL310721B2 (en) | 2015-10-23 | 2025-11-01 | Harvard College | Nucleobase editors and uses thereof |
| EP3439675A4 (en) | 2016-04-08 | 2019-12-18 | Purdue Research Foundation | METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY |
| CN110214183A (zh) | 2016-08-03 | 2019-09-06 | 哈佛大学的校长及成员们 | 腺苷核碱基编辑器及其用途 |
| WO2018031683A1 (en) | 2016-08-09 | 2018-02-15 | President And Fellows Of Harvard College | Programmable cas9-recombinase fusion proteins and uses thereof |
| US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| KR102622411B1 (ko) | 2016-10-14 | 2024-01-10 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| WO2018160622A1 (en) | 2017-02-28 | 2018-09-07 | Endocyte, Inc. | Compositions and methods for car t cell therapy |
| US12390514B2 (en) | 2017-03-09 | 2025-08-19 | President And Fellows Of Harvard College | Cancer vaccine |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
| KR20240116572A (ko) | 2017-03-23 | 2024-07-29 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제 |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| CN111801345A (zh) | 2017-07-28 | 2020-10-20 | 哈佛大学的校长及成员们 | 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物 |
| CA3072960A1 (en) * | 2017-08-15 | 2019-02-21 | Intellia Therapeutics, Inc. | Stabilized nucleic acids encoding messenger ribonucleic acid (mrna) |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| KR20250107288A (ko) | 2017-10-16 | 2025-07-11 | 더 브로드 인스티튜트, 인코퍼레이티드 | 아데노신 염기 편집제의 용도 |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| US11311576B2 (en) | 2018-01-22 | 2022-04-26 | Seattle Children's Hospital | Methods of use for CAR T cells |
| AU2019225174B2 (en) | 2018-02-23 | 2025-11-20 | Endocyte, Inc. | Sequencing method for CAR T cell therapy |
| US12157760B2 (en) | 2018-05-23 | 2024-12-03 | The Broad Institute, Inc. | Base editors and uses thereof |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| WO2020191233A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| US12194089B2 (en) | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
| IL297761A (en) | 2020-05-08 | 2022-12-01 | Broad Inst Inc | Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence |
| US20230348902A1 (en) * | 2020-08-10 | 2023-11-02 | Integral Molecular, Inc. | Methods and compositions for making antibody libraries and antibodies isolated from the same |
| US11918643B2 (en) | 2020-12-22 | 2024-03-05 | CureVac SE | RNA vaccine against SARS-CoV-2 variants |
| US20240084285A1 (en) * | 2021-01-22 | 2024-03-14 | Nanjing GenScript Biotech Co., Ltd. | Method for producing target dna sequence and cloning vector |
| US20240102065A1 (en) | 2021-01-27 | 2024-03-28 | CureVac SE | Method of reducing the immunostimulatory properties of in vitro transcribed rna |
| NL2027654B1 (en) | 2021-02-08 | 2022-09-09 | Nutcracker Therapeutics Inc | Methods for manufacturing a syntetic template |
| CN116004682B (zh) * | 2022-08-19 | 2026-01-16 | 中国人民解放军军事科学院军事医学研究院 | 一种快速无痕制备含长多聚腺嘌呤的mRNA的方法及应用 |
| CN117701602A (zh) * | 2022-08-26 | 2024-03-15 | 深圳瑞吉生物科技有限公司 | 在宿主细胞中稳定存在的多段化PolyA多核苷酸及其应用 |
| EP4608442A1 (en) | 2022-10-28 | 2025-09-03 | GlaxoSmithKline Biologicals S.A. | Nucleic acid based vaccine |
| CN119799695A (zh) * | 2023-10-10 | 2025-04-11 | 深圳瑞吉生物科技有限公司 | 提高mRNA稳定性以及蛋白表达的多元polyA多核苷酸及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030083272A1 (en) * | 1997-09-19 | 2003-05-01 | Lahive & Cockfield, Llp | Sense mrna therapy |
| US6130040A (en) | 1998-01-08 | 2000-10-10 | Lin; Shi-Lung | Method for generating directly covalent bonding between interstrand nucleotides |
| US20010000077A1 (en) | 1998-02-03 | 2001-03-29 | Engelhardt Dean L. | Novel process, construct and conjugate for producing multiple nucleic acid copies |
| AU766146B2 (en) * | 1998-05-26 | 2003-10-09 | University Of Medicine And Dentistry Of New Jersey | System for reproducing and modulating stability and turnover of RNA molecules |
| DE102005046490A1 (de) | 2005-09-28 | 2007-03-29 | Johannes-Gutenberg-Universität Mainz | Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen |
| ATE549408T1 (de) * | 2006-01-12 | 2012-03-15 | Lucigen Corp | Lineare vektoren, wirtszellen und klonverfahren |
| US7723103B2 (en) * | 2007-01-08 | 2010-05-25 | Lucigen Corporation | Vectors, kits and methods for cloning DNA |
| DE102007003321A1 (de) * | 2007-01-17 | 2008-08-21 | Mbb International Group Ag | Verschlusseinrichtung für einen mit Druckgas befüllbaren Druckbehälter eines Kaltgasgenerators |
| WO2008097926A2 (en) * | 2007-02-02 | 2008-08-14 | Yale University | Transient transfection with rna |
| WO2013123559A1 (en) | 2012-02-22 | 2013-08-29 | Monash University | Rna tagging method |
| WO2013143700A2 (en) * | 2012-03-27 | 2013-10-03 | Curevac Gmbh | Artificial nucleic acid molecules comprising a 5'top utr |
| PL3360964T3 (pl) * | 2012-12-06 | 2020-03-31 | Sigma-Aldrich Co. Llc | Modyfikacja i regulacja genomu oparta na crispr |
| EP3031921B1 (en) | 2012-12-12 | 2025-03-12 | The Broad Institute, Inc. | Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications |
| US9650406B2 (en) | 2013-02-28 | 2017-05-16 | Centrillion Technology Holdings Corporation | Reversible terminator molecules and methods of their use |
| WO2016005004A1 (en) * | 2014-07-11 | 2016-01-14 | Biontech Rna Pharmaceuticals Gmbh | Stabilization of poly(a) sequence encoding dna sequences |
| CA3072960A1 (en) * | 2017-08-15 | 2019-02-21 | Intellia Therapeutics, Inc. | Stabilized nucleic acids encoding messenger ribonucleic acid (mrna) |
-
2015
- 2015-10-08 ES ES15848462T patent/ES3015369T3/es active Active
- 2015-10-08 AU AU2015330775A patent/AU2015330775B2/en active Active
- 2015-10-08 EP EP25152831.1A patent/EP4553081A1/en active Pending
- 2015-10-08 EP EP15848462.6A patent/EP3204399B1/en active Active
- 2015-10-08 WO PCT/US2015/054780 patent/WO2016057850A1/en not_active Ceased
- 2015-10-08 US US14/879,023 patent/US9943612B2/en active Active
- 2015-10-08 DK DK15848462.6T patent/DK3204399T3/da active
-
2018
- 2018-04-11 US US15/950,562 patent/US11400169B2/en active Active
-
2021
- 2021-06-04 AU AU2021203655A patent/AU2021203655A1/en not_active Abandoned
-
2022
- 2022-07-11 US US17/811,685 patent/US20230054471A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US9943612B2 (en) | 2018-04-17 |
| US20180272007A1 (en) | 2018-09-27 |
| EP3204399B1 (en) | 2025-01-22 |
| ES3015369T3 (en) | 2025-05-05 |
| WO2016057850A1 (en) | 2016-04-14 |
| CA2963840A1 (en) | 2016-04-14 |
| US11400169B2 (en) | 2022-08-02 |
| AU2015330775A1 (en) | 2017-05-18 |
| EP3204399A4 (en) | 2018-04-25 |
| EP4553081A1 (en) | 2025-05-14 |
| EP3204399A1 (en) | 2017-08-16 |
| AU2021203655A1 (en) | 2021-07-01 |
| US20160243258A1 (en) | 2016-08-25 |
| AU2015330775B2 (en) | 2021-06-24 |
| US20230054471A1 (en) | 2023-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3204399T3 (da) | Lange poly (a)-plasmider og fremgangsmåder til indføring af lange poly (a)-sekvenser i plasmidet | |
| DK4008782T3 (da) | Fremgangsmåder til tilvejebringelse af enkeltstrenget rna | |
| DK3334828T3 (en) | Fremgangsmåde til at øge replikationen af et cirkulært dna-molekyle | |
| DK3386550T3 (da) | Fremgangsmåder til fremstilling og anvendelse af guide nukleinsyrer | |
| DK3471749T3 (da) | Fremgangsmåder og sammensætninger til detektering af en mål-RNA | |
| DK3689609T3 (da) | Transplantatstillads til bruskreparation og en fremgangsmåde til fremstilling af samme | |
| DK3185868T3 (da) | Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme | |
| DK3186376T3 (da) | Fremgangsmåder til forbedring af cas9-medieret manipulationseffektivitet | |
| DK3134506T3 (da) | Fremgangsmåder til oprensning af messenger rna | |
| DK3035649T3 (da) | Systemer og metoder til generering af en entydig enheds-ID | |
| DK3881827T3 (en) | Formulering til administration af rna | |
| DK3294700T3 (da) | Fremgangsmåde til fremstilling af limonen-4-ol | |
| DK3122444T3 (da) | Fremgangsmåde til fremstilling af membraner | |
| DK3398378T3 (da) | Fremgangsmåde til oprettelse af en roaming-forbindelse | |
| DK3275040T3 (da) | Fremgangsmåde og indretning til dannelse af et batteri | |
| DK3229995T3 (da) | Fremgangsmåde for fremstilling af et endestykke | |
| DK3204492T3 (da) | Fremgangsmåde til generering af t-celleforløbere | |
| DK3058632T3 (da) | Fremgangsmåde og indretning til fremstilling af et havkabel og dermed fremstillet havkabel | |
| EP3148179A4 (en) | Focusing state prompting method and shooting device | |
| DK3230054T3 (da) | Apparat og fremgangsmåde til fremstilling af et fleksibelt rør | |
| DK3373813T3 (da) | Indretning til ekstraktion af plasma | |
| DK3290769T3 (da) | Beslag til forbindelse til et rørformet element, rørforbindelse og fremgangsmåde til forbindelse af et beslag til et rørformet element | |
| DK3397733T3 (da) | Anordning og fremgangsmåde til fremstilling af en gas | |
| DK3215598T3 (da) | Fremgangsmåde til drift af en røreindretning og en forgasningsbeholder | |
| DK3091882T3 (da) | Fremgangsmåde og indretning til fremstilling af en drik |